Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Page

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature|March 28, 1970
Abnormal zygote development in mice after paternal exposure to a chemical mutagenS S Epstein, S R Joshi, E Arnold, et al.
Genetics|July 1, 1970
Fertilization and early embryonic development subsequent to mating with TEPA-treated male miceS R Joshi, E C Page, E Arnold, et al.
Journal of Rehabilitation|April 1, 1981
Assertiveness training groups with the disabled. A pilot studyE C Page, B Holland, M E Rand, et al.
Psycho-Oncology|August 17, 2017
Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancerC Moynihan, E K Bancroft, A Mitra, et al.
British Journal of Cancer|August 26, 2010
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosisS M Edwards, D G R Evans, Q Hope, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature|March 28, 1970
Abnormal zygote development in mice after paternal exposure to a chemical mutagenS S Epstein, S R Joshi, E Arnold, et al.
Genetics|July 1, 1970
Fertilization and early embryonic development subsequent to mating with TEPA-treated male miceS R Joshi, E C Page, E Arnold, et al.
Journal of Rehabilitation|April 1, 1981
Assertiveness training groups with the disabled. A pilot studyE C Page, B Holland, M E Rand, et al.
Psycho-Oncology|August 17, 2017
Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancerC Moynihan, E K Bancroft, A Mitra, et al.
British Journal of Cancer|August 26, 2010
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosisS M Edwards, D G R Evans, Q Hope, et al.
Pageof 1